Could anti-inflammatory actions of catecholamines explain the possible beneficial effects of supranormal oxygen delivery in critically ill surgical patients?

[1]  S. Takiguchi,et al.  Relationship of mortality to increasing oxygen delivery in patients > or = 50 years of age: a prospective, randomized trial. , 1998, Critical care medicine.

[2]  C. Natanson,et al.  Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. , 1997, Critical care medicine.

[3]  M. Weyand,et al.  Effects of Dopexamine on Creatinine Clearance, Systemic Inflammation, and Splanchnic Oxygenation in Patients Undergoing Coronary Artery Bypass Grafting , 1997, Anesthesia and analgesia.

[4]  Not Available Not Available,et al.  Tissue hypoxia: How to detect, how to correct, how to prevent , 1996 .

[5]  R. Bone,et al.  Immunologic Dissonance: A Continuing Evolution in Our Understanding of the Systemic Inflammatory Response Syndrome (SIRS) and the Multiple Organ Dysfunction Syndrome (MODS) , 1996, Annals of Internal Medicine.

[6]  M. Burdick,et al.  The Association between Mortality Rates and Decreased Concentrations of Interleukin-10 and Interleukin-1 Receptor Antagonist in the Lung Fluids of Patients with the Adult Respiratory Distress Syndrome , 1996, Annals of Internal Medicine.

[7]  E. Vizi,et al.  Cytokine production and its manipulation by vasoactive drugs. , 1996, New horizons.

[8]  A. Judd,et al.  Dopamine increases interleukin 6 release and inhibits tumor necrosis factor release from rat adrenal zona glomerulosa cells in vitro. , 1996, European Journal of Endocrinology.

[9]  E. Vizi,et al.  Modulation of lipopolysaccharide-induced tumor necrosis factor-α and nitric oxide production by dopamine receptor agonists and antagonists in mice , 1996 .

[10]  T. Yen,et al.  Perioperative plasma concentrations of tumor necrosis factor-alpha and interleukin-6 in infected patients. , 1996, Critical care medicine.

[11]  D. Cook,et al.  Maximizing oxygen delivery in critically ill patients: a methodologic appraisal of the evidence. , 1996, Critical care medicine.

[12]  T. van der Poll,et al.  Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. , 1996, The Journal of clinical investigation.

[13]  A. Webb,et al.  Goal-directed therapy with dopexamine, dobutamine, and volume expansion: effects of systemic oxygen transport on hepatic ultrastructure in porcine sepsis. , 1995, Critical care medicine.

[14]  P. Pelosi,et al.  A Trial of Goal-Oriented Hemodynamic Therapy in Critically Ill Patients , 1995 .

[15]  T. Standiford,et al.  Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. , 1995, Journal of immunology.

[16]  W. Shoemaker,et al.  Prospective, randomized trial of survivor values of cardiac index, oxygen delivery, and oxygen consumption as resuscitation endpoints in severe trauma. , 1995, The Journal of trauma.

[17]  J. Keiser,et al.  Role of epinephrine in TNF and IL-6 production from isolated perfused rat liver. , 1995, The American journal of physiology.

[18]  E. Ruokonen,et al.  Gastric mucosal pH does not reflect changes in splanchnic blood flow after cardiac surgery. , 1995, British journal of anaesthesia.

[19]  P. Kragsbjerg,et al.  Serum concentrations of interleukin-6, tumour necrosis factor-alpha, and C-reactive protein in patients undergoing major operations. , 1995, The European journal of surgery = Acta chirurgica.

[20]  Barton Mh,et al.  Pentoxifylline inhibits mediator synthesis in an equine in vitro whole blood model of endotoxemia. , 1994 .

[21]  P. Marik,et al.  The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. , 1994, JAMA.

[22]  C. Hinds,et al.  Elevation of systemic oxygen delivery in the treatment of critically ill patients. , 1994, The New England journal of medicine.

[23]  T. van der Poll,et al.  Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood , 1994, Infection and immunity.

[24]  P. T. Phang,et al.  The oxygen delivery/consumption controversy. Approaches to management of the critically ill. , 1994, American journal of respiratory and critical care medicine.

[25]  P. Crone,et al.  Effect of maximizing oxygen delivery on morbidity and mortality rates in critically ill patients: a prospective, randomized, controlled study. , 1994, Critical care medicine.

[26]  E. Bennett,et al.  A randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high-risk surgical patients. , 1993, JAMA.

[27]  P. T. Phang,et al.  Identification of the critical oxygen delivery for anaerobic metabolism in critically ill septic and nonseptic humans. , 1993, JAMA.

[28]  G. Monastra,et al.  Beta-adrenergic receptors mediate in vivo the adrenaline inhibition of lipopolysaccharide-induced tumor necrosis factor release. , 1993, Immunology letters.

[29]  Philip Smith,et al.  Effect of maximizing oxygen delivery on morbidity and mortality rates in critically ill patients: A prospective, randomized, controlled study , 1993, Critical care medicine.

[30]  J. Vincent,et al.  Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. , 1993, Chest.

[31]  W. Shoemaker,et al.  Prospective trial of supranormal values as goals of resuscitation in severe trauma. , 1992, Archives of surgery.

[32]  E. Rackow,et al.  Elevation of cardiac output and oxygen delivery improves outcome in septic shock. , 1992, Chest.

[33]  C. Hunter,et al.  Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists. , 1992, Journal of immunology.

[34]  A. Dubin,et al.  Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients , 1992, The Lancet.

[35]  B. Beutler,et al.  Effect of amrinone on tumor necrosis factor production in endotoxic shock. , 1992, Circulatory shock.

[36]  W. Fraser,et al.  Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. , 1990, Clinical science.

[37]  Schade Uf.  Pentoxifylline increases survival in murine endotoxin shock and decreases formation of tumor necrosis factor. , 1990 .

[38]  U. Schade.  Pentoxifylline increases survival in murine endotoxin shock and decreases formation of tumor necrosis factor. , 1990, Circulatory shock.

[39]  W. Shoemaker,et al.  Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. , 1988, Chest.

[40]  T C Chalmers,et al.  A method for assessing the quality of a randomized control trial. , 1981, Controlled clinical trials.